The constitutively active tyrosine-kinase BCR/ABL1 oncogene plays a key role in human chronic myeloid leukemia development and disease maintenance, and determines most of the features of this leukemia. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.